CBD and Atherosclerosis

Peer-reviewed studies into the potential effects of Cannabidiol and atherosclerosis

On this page, CBD and Atherosclerosis, you will find research pertaining to the use of Cannabidiol and Cannabinoids and its possible effects on Atherosclerosis. The information below is not meant to influence your opinion, but rather give you access to a wealth of scientific literature in an attempt to make and educated and informed choice. Click Here to see all of the conditions that have been researched alongside CBD and Atherosclerosis. If you have any questions pertaining to the research, please email us at info@hempicated.com.

The Role of the Endocannabinoid System in Atherosclerosis

From the abstract:

A growing body of evidence suggests that endocannabinoid signalling plays a critical role in the pathogenesis of atherogenesis and its clinical manifestations… Endocannabinoids released from endothelial cells, macrophages or platelets, reduce hypertension in rodents, a major risk factor for atherosclerosis.

Cannabinoid receptors in atherosclerosis

From the abstract:

The immunomodulatory capacity of cannabinoids is now well established and suggests a broad therapeutic potential of cannabinoids for a variety of conditions, including atherosclerosis.

The potential use of cannabidiol in the therapy of metabolic syndrome 

From the abstract:

Similar to the peroxisome proliferator-activated receptor-gamma agonists, [cannabidiol] may also help the differentiation of adipocytes. Cannabidiol has an immunomodulating effect, as well, that helps effective in fighting ischaemic diseases, the most harmful complications of metabolic syndrome.